Acorda’s CMO, Carrazana, To Step Down in January

Xconomy New York — 

Acorda Therapeutics (NASDAQ: ACOR), of Ardsley, NY, said on Monday that chief medical officer Enrique Carrazana will step down from his post on Jan. 4. Burkhard Blank, a former CMO of Boehringer Ingelheim, will take Carrazana’s place on an interim basis.